重点监控-话题@MedSci

#重点监控#

30篇内容 | 1295人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1949104, encodeId=f753194910400, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=多地跟进重点监控，166品种受限！中药注射剂仍是增补重点！, objectType=article, longId=180966, objectId=18cd18096680, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18cd18096680, replyNumber=0, likeNumber=88, createdTime=2020-06-19, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18cd18096680, moduleTitle=多地跟进重点监控，166品种受限！中药注射剂仍是增补重点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18cd18096680)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949102, encodeId=93e71949102de, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=重点监控药品，全国很低价要曝光, objectType=article, longId=178934, objectId=37041e893431, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37041e893431, replyNumber=0, likeNumber=74, createdTime=2019-11-19, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37041e893431, moduleTitle=重点监控药品，全国很低价要曝光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37041e893431)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949105, encodeId=cd8f1949105d6, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=国家卫生健康委：数千家医院，重点监控高值耗材, objectType=article, longId=184546, objectId=5fe118454612, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe118454612, replyNumber=0, likeNumber=66, createdTime=2020-08-27, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe118454612, moduleTitle=国家卫生健康委：数千家医院，重点监控高值耗材, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fe118454612)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949101, encodeId=35101949101d3, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=50个药被限制使用、重点监控, objectType=article, longId=175362, objectId=deb91e5362d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deb91e5362d2, replyNumber=0, likeNumber=70, createdTime=2020-01-31, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deb91e5362d2, moduleTitle=50个药被限制使用、重点监控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deb91e5362d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949098, encodeId=1f931949098f2, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=20种药品被国家重点监控，专家：对医保控费具有重要意义, objectType=article, longId=174712, objectId=2a851e471270, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a851e471270, replyNumber=0, likeNumber=66, createdTime=2020-04-08, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a851e471270, moduleTitle=20种药品被国家重点监控，专家：对医保控费具有重要意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a851e471270)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949100, encodeId=f6ff1949100db, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=深读 ▎国家公布重点监控药品目录会对行业产生什么样的影响？, objectType=article, longId=175161, objectId=72031e5161e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72031e5161e1, replyNumber=0, likeNumber=63, createdTime=2020-06-16, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72031e5161e1, moduleTitle=深读 ▎国家公布重点监控药品目录会对行业产生什么样的影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72031e5161e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949096, encodeId=7efb19490967c, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=通知！20个药被重点监控, objectType=article, longId=163396, objectId=53c216339673, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53c216339673, replyNumber=0, likeNumber=59, createdTime=2019-09-15, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53c216339673, moduleTitle=通知！20个药被重点监控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53c216339673)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949106, encodeId=02ab194910684, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=中注协全新“警告”：年报审计医药行业被点名重点监控！这些爆雷点需警惕, objectType=article, longId=185712, objectId=285a185e12ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=285a185e12ae, replyNumber=0, likeNumber=74, createdTime=2020-08-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=285a185e12ae, moduleTitle=中注协全新“警告”：年报审计医药行业被点名重点监控！这些爆雷点需警惕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=285a185e12ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949097, encodeId=7e9f194909e32, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=刚刚！福建发文，医保用量大药品，重点监控！, objectType=article, longId=163614, objectId=18a91636147c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18a91636147c, replyNumber=0, likeNumber=75, createdTime=2019-07-26, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18a91636147c, moduleTitle=刚刚！福建发文，医保用量大药品，重点监控！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18a91636147c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949103, encodeId=2d61194910349, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=这些中药大品种，被重点监控, objectType=article, longId=179656, objectId=37991e96561e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37991e96561e, replyNumber=0, likeNumber=72, createdTime=2020-07-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37991e96561e, moduleTitle=这些中药大品种，被重点监控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37991e96561e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949099, encodeId=7f221949099ec, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=官方公布：第一批国家重点监控合理用药药品目录, objectType=article, longId=174735, objectId=09051e4735c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09051e4735c5, replyNumber=0, likeNumber=74, createdTime=2019-10-25, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09051e4735c5, moduleTitle=官方公布：第一批国家重点监控合理用药药品目录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09051e4735c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949095, encodeId=6db7194909512, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=刚刚！这些药，被重点监控, objectType=article, longId=159169, objectId=e207159169d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e207159169d4, replyNumber=0, likeNumber=56, createdTime=2019-11-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e207159169d4, moduleTitle=刚刚！这些药，被重点监控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e207159169d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949094, encodeId=1d3219490947b, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=带量采购结果公布，过一致性评价药品命中率高，重点监控品种暂停交易, objectType=article, longId=153492, objectId=54f715349287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54f715349287, replyNumber=0, likeNumber=70, createdTime=2018-12-20, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54f715349287, moduleTitle=带量采购结果公布，过一致性评价药品命中率高，重点监控品种暂停交易, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54f715349287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949093, encodeId=abc319490930a, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=244家医院耗材被重点监控，费用异常全省曝光！, objectType=article, longId=153036, objectId=849515303689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=849515303689, replyNumber=0, likeNumber=59, createdTime=2019-05-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=849515303689, moduleTitle=244家医院耗材被重点监控，费用异常全省曝光！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=849515303689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949091, encodeId=6ac01949091cf, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=又有64个药被重点监控！头孢、氯吡格雷、阿托伐他汀…, objectType=article, longId=146793, objectId=eff3146e9399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eff3146e9399, replyNumber=0, likeNumber=61, createdTime=2018-12-14, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eff3146e9399, moduleTitle=又有64个药被重点监控！头孢、氯吡格雷、阿托伐他汀…, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eff3146e9399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949089, encodeId=b5a4194908992, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=又一省发文，重点监控中药注射剂, objectType=article, longId=141540, objectId=6580141540c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6580141540c4, replyNumber=0, likeNumber=65, createdTime=2018-12-14, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6580141540c4, moduleTitle=又一省发文，重点监控中药注射剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6580141540c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949088, encodeId=5342194908881, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=又有一批药，被重点监控！, objectType=article, longId=136834, objectId=a5ea13683477, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5ea13683477, replyNumber=0, likeNumber=0, createdTime=2019-03-07, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5ea13683477, moduleTitle=又有一批药，被重点监控！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5ea13683477)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949085, encodeId=810a1949085c6, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=40个中药饮片被重点监控, objectType=article, longId=124157, objectId=a99a12415ee0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a99a12415ee0, replyNumber=0, likeNumber=52, createdTime=2018-11-23, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99a12415ee0, moduleTitle=40个中药饮片被重点监控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a99a12415ee0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949092, encodeId=2b3119490921d, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=南京：这23个药，被重点监控（附名单）, objectType=article, longId=149516, objectId=3491149516a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3491149516a9, replyNumber=0, likeNumber=60, createdTime=2019-01-06, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3491149516a9, moduleTitle=南京：这23个药，被重点监控（附名单）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3491149516a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949082, encodeId=0c76194908209, content=<a href='/topic/show?id=72459589567' target=_blank style='color:#2F92EE;'>#重点监控#</a>, objectTitle=宁夏开展重点监控药品管理，医生屡开超常处方可取消处方权, objectType=article, longId=122339, objectId=07eb122339d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07eb122339d3, replyNumber=0, likeNumber=70, createdTime=2018-01-28, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07eb122339d3, moduleTitle=宁夏开展重点监控药品管理，医生屡开超常处方可取消处方权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07eb122339d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重点监控

2020-05-29

智慧医人 (审核中...)

前往app查看评论内容

#重点监控#

多地跟进重点监控，166品种受限！中药注射剂仍是增补重点！

2020-06-19

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

重点监控药品，全国很低价要曝光

2019-11-19

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

国家卫生健康委：数千家医院，重点监控高值耗材

2020-08-27

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

50个药被限制使用、重点监控

2020-01-31

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

20种药品被国家重点监控，专家：对医保控费具有重要意义

2020-04-08

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

深读 ▎国家公布重点监控药品目录会对行业产生什么样的影响？

2020-06-16

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

通知！20个药被重点监控

2019-09-15

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

中注协全新“警告”：年报审计医药行业被点名重点监控！这些爆雷点需警惕

2020-08-21

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

刚刚！福建发文，医保用量大药品，重点监控！

2019-07-26

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

这些中药大品种，被重点监控

2020-07-21

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

官方公布：第一批国家重点监控合理用药药品目录

2019-10-25

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

刚刚！这些药，被重点监控

2019-11-28

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

带量采购结果公布，过一致性评价药品命中率高，重点监控品种暂停交易

2018-12-20

hb2008ye (审核中...)

前往app查看评论内容

#重点监控#

244家医院耗材被重点监控，费用异常全省曝光！

2019-05-26

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

又有64个药被重点监控！头孢、氯吡格雷、阿托伐他汀…

2018-12-14

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

又一省发文，重点监控中药注射剂

2018-12-14

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

又有一批药，被重点监控！

2019-03-07

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

40个中药饮片被重点监控

2018-11-23

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

南京：这23个药，被重点监控（附名单）

2019-01-06

bluefate121 (审核中...)

前往app查看评论内容

#重点监控#

宁夏开展重点监控药品管理，医生屡开超常处方可取消处方权

2018-01-28

科室
- - 订阅+
  - 更多科室
工具
服务